Navigation Links
LaVoie Group Selected by Vaccine Developer, Profectus BioSciences, as Agency of Record
Date:4/29/2009

SALEM, Mass., April 29 /PRNewswire/ -- LaVoie Group, a life science-focused strategic communications agency, announced today that it has been selected as public relations agency of record by therapeutic vaccine development company, Profectus BioSciences, Inc.

Donna L. LaVoie, President & CEO of LaVoie Group, commented, "We are delighted to represent Profectus during an important stage in the company's clinical development. We look forward to working with them to communicate their message to appropriate investors, media, pharmaceutical partners and physicians."

Shawn Patrick O'Brien, Chief Executive Officer, commented, "Profectus BioSciences has a strong value proposition since the vaccine sector has emerged as a key revenue generator for big pharma with favorable legislation, relatively low development risk, exemplary commercial success of several blockbuster vaccines, and therapeutic vaccines being more attractive than preventative vaccines. By retaining LaVoie Group, I am confident that we will deliver our message more effectively to our key constituencies."

About Profectus BioSciences, Inc.

Profectus BioSciences is an innovative research and development vaccine company devoted to advancing the treatment and prevention of chronic viral diseases. The Profectus proprietary vaccine design approach combines its pDNA and rVSV platforms via a unique prime boost strategy to enhance immune response. Profectus' broad product pipeline will address Human Immunodeficiency Virus (HIV), Hepatitis C Virus (HCV), Human Papilloma Virus (HPV) and Herpes Simplex Virus (HSV).

The Profectus portfolio has received over $100 million in funding from multiple sources including National Institutes of Health (NIH), Cross Atlantic Capital Partners and through private investments. Profectus deploys these resources in support of its proprietary prime boost vaccines and its anti-inflammatory sma
'/>"/>

SOURCE LaVoie Group
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. LaVoie Group Adds Bio-Surgery Company, Pegasus Biologics, to Its Life Sciences Agency Roster
2. Avicena Group to Present at Noble Financial Conference
3. Chrome Group to Seek Listing for Some of its Subsidiaries
4. Dr. Amit Dhawan Promoted to Medical Director for The Mattson Jack Group
5. Reed Group to Provide MDA Internet Disability Duration Guidelines to U.S. Navy
6. SportCoatings; The North American Booster Club Association (NABCA); the Coatings Specialist Group New Booster Program Goes High Tech With Invisible Antimicrobial Defense
7. Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases
8. Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Completion of $2,277,000 Equity Financing
9. ThirdBiotech Networking Group Launches
10. Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Appointment of Mark C. Mirken as its President and Chief Operating Officer
11. Reed Group Ltd. Announces Enterprise License for New Zealands Accident Compensation Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/12/2010)... is taking strides to expand their Product and Material Testing Division ... ... Minneapolis, MN (PRWEB) March 12, 2010 -- DDL , leader ... to expand their Product and Material Testing Division by promoting Mark ... medical device manufacturers get to market for almost 20 years. ...
(Date:3/11/2010)... Drug Administration (FDA) has approved a five-day dosing regimen for Dacogen® (decitabine) for Injection to treat patients with myelodysplastic syndromes (MDS), a group of bone ... ... , ... ... ...
(Date:3/11/2010)... has signed a definitive agreement with Elan Pharmaceuticals, Inc. (a subsidiary of Elan Corporation, plc) ( ELN) ("Elan") to acquire the analgesic therapy, PRIALT(R) (ziconotide ... ... ... ... ...
(Date:3/11/2010)... a biopharmaceutical company developing innovative immune-based biologics, today announced that it has entered ... for Sick Children (SickKids) in Toronto, Ontario , granting Trillium exclusive worldwide ... transplantation and cancer. , ... ... , ...
Breaking Biology Technology:DDL Expands the Product & Material Testing Division 2DDL Expands the Product & Material Testing Division 3FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 2FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 3FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 4FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 5FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 6FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 7FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 8Azur Pharma Announces the Signing of a Definitive Agreement to Acquire PRIALT(R) From Elan 2Azur Pharma Announces the Signing of a Definitive Agreement to Acquire PRIALT(R) From Elan 3Azur Pharma Announces the Signing of a Definitive Agreement to Acquire PRIALT(R) From Elan 4Azur Pharma Announces the Signing of a Definitive Agreement to Acquire PRIALT(R) From Elan 5Azur Pharma Announces the Signing of a Definitive Agreement to Acquire PRIALT(R) From Elan 6Trillium expands immunology pipeline and enters stem cell field through in-licensing of two new programs 2Trillium expands immunology pipeline and enters stem cell field through in-licensing of two new programs 3
... years of life sciences marketing experience to CyntellectSAN ... sciences company leading the development and commercialization of ... that it has appointed Dr. Stella Redpath as ... Health product line and Dr. Baggi Somasundaram as ...
... Bronowski,s Ascent of Man, as well as hundreds of other award winning ... ... (PRWEB) January 15, 2009 -- Stream the Bard, James Burke,s Connections, Jacob ... programs now available at ambrosedigital.com ., , , , ,The collection ...
... La., Jan. 14 Lafayette General Medical ... hospital in Louisiana to use a,proprietary molecular ... accurately diagnose respiratory infectious diseases. This technology,called ... allows,physicians to test for multiple infections, both ...
Other Biology Technology:Cyntellect Appoints Former Millipore and BD Biosciences Executives to Head Up its Product Marketing Efforts 2New Video Streaming Site Created by Ambrose Video Publishing 2New Video Streaming Site Created by Ambrose Video Publishing 3Lafayette General Medical Center is the First Hospital in Louisiana to Use Genetic-Based Technology to Test for Respiratory Disease 2
(Date:3/11/2010)... wisdom holds that living cells interact with their ... a result many therapies for the treatment of cancer ... focus on drugs that block or disrupt harmful chemical ... have been opened with scientific evidence for a never ... and respond to physical forces. , A team of ...
(Date:3/11/2010)... a chunk of rock and dust about 1,900 feet in ... born, and perhaps, shed light on how life began. It ... time capsule from before the birth of our solar system," ... Greenbelt, Md., one of the leaders of Goddard,s effort to ... from RQ36. , If selected, Goddard will provide overall ...
(Date:3/11/2010)... the body, they follow a complex pattern similar ... searching for food, a team of Vanderbilt researchers ... for drug development: Incorporating this basic behavior into ... migration, such as embryo development, bone remodeling, wound ... accuracy with which these models can predict the ...
Breaking Biology News(10 mins):Berkeley scientists find new way to get physical in the fight against cancer 2Berkeley scientists find new way to get physical in the fight against cancer 3Berkeley scientists find new way to get physical in the fight against cancer 4Proposed mission would return sample from asteroid 'time capsule' 2Proposed mission would return sample from asteroid 'time capsule' 3Proposed mission would return sample from asteroid 'time capsule' 4Proposed mission would return sample from asteroid 'time capsule' 5Human cells exhibit foraging behavior like amoebae and bacteria 2Human cells exhibit foraging behavior like amoebae and bacteria 3Big Whoppers of 2009 from FactCheck org 63927 1Big Whoppers of 2009 from FactCheck org 63927 2National Disability Lawyer Gets 2010 Social Security Website Upgrade 63924 1National Disability Lawyer Gets 2010 Social Security Website Upgrade 63924 2Dont Invite Holiday Stress Into Your Home 63920 1Dont Invite Holiday Stress Into Your Home 63920 2
... 2008 (Oakland, Calif.) - Depressed pregnant women have twice ... no symptoms of depression, according to a new study ... is published online in the Oxford University Press,s journal ... Society of Human Reproduction and Embryology. , The study ...
... Technology Integrates with,Citrix Password Manager Single-Sign On ... Calif., Oct. 22 Fujitsu Computer Products ... computer products including,hard disk drives, peripherals and ... LOGONDIRECTOR has been verified as Citrix,Ready(TM). The ...
... McGill University, along with colleagues from the California Institute ... and other institutions, have unearthed crystalline magnetic fossils of ... the boundary of the Paleocene and Eocene epochs, some ... 21 in the Proceedings of the National Academy ...
Other Biology News:Depression during pregnancy can double risk of preterm delivery 2Fujitsu PalmSecure LOGONDIRECTOR Verified as Citrix Ready 2Fujitsu PalmSecure LOGONDIRECTOR Verified as Citrix Ready 3Fujitsu PalmSecure LOGONDIRECTOR Verified as Citrix Ready 4Earlier global warming produced a whole new form of life 2